Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study ; volume:12 ; number:2 ; day:1 ; month:11 ; year:2024 ; pages:1-23 ; date:12.2024
In Silico Pharmacology ; 12, Heft 2 (1.11.2024), 1-23, 12.2024

Creator: Vu, Giang Huong
Nguyen, Hai Duc

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40203-024-00267-4

URN: urn:nbn:de:101:1-2501212117237.332169718020

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vu, Giang Huong
Nguyen, Hai Duc
SpringerLink (Online service)

Other Objects (12)

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease

Hochschulschrift

A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Alzheimer’s disease: insights from a network medicine perspective

Hochschulschrift

A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease

Hochschulschrift

A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Alzheimer’s disease: insights from a network medicine perspective

Hochschulschrift

A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease

Hochschulschrift

A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Alzheimer’s disease: insights from a network medicine perspective

Hochschulschrift

A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease

A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Alzheimer’s disease: insights from a network medicine perspective

A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease

A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Alzheimer’s disease: insights from a network medicine perspective

A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease

A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

Alzheimer’s disease: insights from a network medicine perspective

A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease

In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Related objects

Reset password